Market Live Email

Astrazeneca to invest $2bn in Summit Therapeutics, AG Barr backs FY expectations

By Iain Gilbert

Date: Tuesday 29 Sep 2026

(Sharecast News) - LONDON PRE-OPEN

The FTSE 100 was expected to open 23.8 points higher ahead of the bell on Tuesday, after wrapping up the previous session 0.10% softer at 10,684.88.


STOCKS TO WATCH

Astrazeneca will invest $2bn in US biopharma Summit Therapeutics, the British drugs...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page